AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Biospace

Published November 5, 2026 · Updated November 6, 2026

SK Biopharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for Cenobamate

Read the full story at Biospace

The trial enrolled 169 patients across 122 sites in 12 countries, including the U.S. , South Korea and countries in Europe. ... Psychedelics · Compass to.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics south america